Establishment of Hybrid Cell Lines Producing Monoclonal Antibodies to a Synthetic Peptide from the E1 Region of the Hepatitis C Virus

References

• Chen , S. and Morgan , T. 2006 . The natural history of hepatitis C virus (HCV) infection. Int . J. Med. Sci. , 3 : 47 – 52 .
   Google Scholar
• Mohamed , M. , Bakr , I. , El‐Hoseiny , M. , Arafa , N. , Hassan , A. , Ismail , S. , Anwar , M. , Attala , M. , Rekacewicz , C. , Zalata , K. , Abdel‐Hamid , M. , Esmat , G. and Fontanet , A. 2006 . HCV‐related morbidity in a rural community of . Egypt. J. Med. Virol. , 78 ( 9 ) : 1185 – 1189 .
   PubMed Web of Science ®Google Scholar
• Talaat , M. , Kandeel , A. , Rasslan , O. , Hajjeh , R. , Hallaj , Z. , El‐Sayed , N. and Mahoney , F. 2006 . Evolution of infection control in Egypt: achievements and challenges. Am . J. Infect. Contr. , 34 ( 4 ) : 193 – 200 .
   PubMed Web of Science ®Google Scholar
• Strickland , G. 2006 . Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of latrogenic and biological factors . Hepatology , 43 ( 5 ) : 915 – 922 .
   PubMed Web of Science ®Google Scholar
• Abdel‐Hamid , M. , El‐Daly , M. , Molnegren , V. , El‐Kafrawy , S. , Abdel‐Latif , S. , Esmat , G. , Strickland , G. , Loffredo , C. , Albert , J. and Widell , A. 2007 . Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma . J. Gen. Virol. , 88 ( Pt5 ) : 1526 – 1531 .
   PubMedGoogle Scholar
• El‐Awady , M. , Tabll , A. , Atef , K. , Yousef , S. , Omran , M. , El‐Abd , Y. , Bader‐Eldin , N. , Salem , A. , Zohny , S. and El‐Garf , W. 2006 . Antibody to E1 peptide of hepatitis C virus genotype 4 inhibits virus binding and entry to HepG2 cells in vitro . World J. Gastroenterol. , 12 ( 16 ) : 2530 – 2535 .
   PubMed Web of Science ®Google Scholar
• El‐Awady , M. , Tabll , A. , Redwan , E. , Youssef , S. , Omran , M. , Thakeb , F. and Demellawy , M. 2005 . Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: Binding and entry. World J. Gastroenterol . 11 ( 33 ) : 5203 – 5208 .
   Google Scholar
• El‐Awady , M. , Tabll , A. , El‐Abd , Y. , Bahgat , M. , Shoeb , H. , Youssef , S. , Bader El‐Din , N. , Redwan , El‐R. , El‐Demellawy , M. , Omran , M. , El‐Garf , W. and Goueli , S. 2006 . HepG2 cells support viral replication and gene expression of hepatitis C virus genotype 4 in vitro . World J. Gastroenterol. , 14 ( 12(30) : 4836 – 4842 .
   Google Scholar
• El‐Awady , M. , El Abd , Y. , Shoeb , H. , Tabll , A. , Hosny , A. , El Shenawy , R. , Atef , K. , Bader El Din , N. and Bahgat , M. 2006 . Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis . Virol. J. , 1 ( 3(1) : 67
   Google Scholar
• Kohler , G. and Milstein , C. 1975 . Continuous cultures of fused cells secreting antibody of predefined specificity . Nature , 7 ( 5517 ) : 495 – 497 .
   Google Scholar
• Laemmli , U. 1970 . Cleavage of structural proteins during the assembly of the head of bacteriophage T4 . Nature , 227 : 680 – 685 .
   PubMed Web of Science ®Google Scholar
• Sy , T. and Jamal , M. 2006 . Epidemiology of hepatitis C virus (HCV) infection . Int. J. Med. Sci. , 3 ( 2 ) : 41 – 46 .
   PubMedGoogle Scholar
• Tarr , A. , Owsianka , A. , Timms , J. , McClure , C. , Brown , R. , Hickling , T. , Pietschmann , T. , Bartenschlager , R. , Patel , A. H. and Ball , J. K. 2006 . Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33 . Hepatology , 43 ( 3 ) : 592 – 601 .
   PubMed Web of Science ®Google Scholar
• Dreux , M. , Pietschmann , T. , Granier , C. , Voisset , C. , Ricard‐Blum , S. , Mangeot , P. , Keck , Z. , Foung , S. , Vu‐Dac , N. , Dubuisson , J. , Bartenschlager , R. and Lavillette , D. 2006 . High density lipoprotein inhibits hepatitis C virus‐neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI . J. Biol. Chem. , 281 ( 27 ) : 18285 – 18295 .
   PubMed Web of Science ®Google Scholar
• Eren , R. , Landstein , D. , Terkieltaub , D. , Nussbaum , O. , Zauberman , A. , Ben‐Porath , J. , Gopher , J. , Buchnick , R. , Kovjazin , R. , Rosenthal‐Galili , Z. , Aviel , S. , Ilan , E. , Shoshany , Y. , Neville , L. , Waisman , T. , Ben‐Moshe , O. , Kischitsky , A. , Foung , S. , Keck , Z. , Pappo , O. , Eid , A. , Jurim , O. , Zamir , G. , Galun , E. and Dagan , S. 2006 . Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients . J. Virol. , 80 ( 6 ) : 2654 – 2664 .
   PubMed Web of Science ®Google Scholar
• Petit , M. , Jolivet‐Reynaud , C. , Peronnet , E. , Michal , Y. and Trepo , C. 2003 . Mapping of a conformational epitope shared between E1 and E2 on the serum‐derived human hepatitis C virus envelope . J. Biol. Chem. , 278 ( 45 ) : 44385 – 44392 .
   PubMed Web of Science ®Google Scholar
• Cagnon , L. , Wagaman , P. , Bartenschlager , R. , Pietschmann , T. , Gao , T. , Kneteman , N. , Tyrrell , D. , Bahl , C. , Niven , P. , Lee , S. and Simmen , K. 2004 . Application of the trak‐C HCV core assay for monitoring antiviral activity in HCV replication systems . J. Virol. Meth. , 118 ( 1 ) : 23 – 31 .
   PubMed Web of Science ®Google Scholar
• Shi , H. , Xie , L. , Huang , D. Z. and He , L. X. 2006 . Detection of HCV antigen in the serum by immunodotting . 22 ( 3 ) : 336 – 338 . Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
   Google Scholar
• Attallah , A. , Ismail , H. , Tabll , A. , Shiha , G. and El‐Dosoky , I. 2003 . A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection . J. Immunoassay Immunochem. , 24 ( 4 ) : 395 – 407 .
   PubMed Web of Science ®Google Scholar
• Leary , T. , Gutierrez , R. , Muerhoff , A. , Birkenmeyer , L. , Desai , S. and Dawson , G. 2006 . A chemiluminescent, magnetic particle‐based immunoassay for the detection of hepatitis C virus core antigen in human serum or plasma . J. Med. Virol. , 78 ( 11 ) : 1436 – 1440 .
   PubMed Web of Science ®Google Scholar
• Xie , L. , Wu , X. , Huang , D. , Chen , H. , He , L. , Wang , J. and Han , D. 2007 . Clinical application and analysis of hepatitis C virus NS3 antigen detection by ELISA in human serum . Chin. Med. J. (Engl.) , 20 ( 120(4) : 294 – 299 .
   Google Scholar
• Doskeland , S. and Berdal , B. 1980 . Bacterial antigen detection in body fluids: methods for rapid antigen concentration and reduction of nonspecific reactions . J. Clin. Microbiol. , 11 ( 3 ) : 80 – 384 .
   Google Scholar
• De Jonge , N. , Fillie , Y. E. and Deelder , A. 1987 . A simple and rapid treatment (trichloroacetic acid precipitation) of serum samples to prevent non‐specific reactions in the immunoassay of a proteoglycan . J. Immunol. Meth. , 99 : 195 – 197 .
   PubMed Web of Science ®Google Scholar
• Tanaka , E. , Kiyosawa , K. , Matsumoto , A. , Yanagihara , O. and Ohta , Y. 1996 . Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alpha . Hepatology , 23 : 1330 – 1333 .
   PubMedGoogle Scholar
• Tanaka , E. , Ohue , C. , Aoyagi , K. , Yamaguchi , K. , Yagi , S. , Kiyosawa , K. and Alter , H. 2000 . Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV‐RNA . Hepatology , 32 ( 2 ) : 388 – 393 .
   PubMed Web of Science ®Google Scholar